The invention relates to a foam material (FP) comprising a polymer composition (C) comprising at least a polyphenylene sulfide polymer (PPS) and at least one functionalized elastomer (E). The present invention also relates to a process for the manufacture of said foam material and to an article (A) including said foam material (FP), for example a composite material.

When a polymer gel has excellent mechanical strength and an ability to maintain surface wetness for a longer time, the polymer gel may be very widely applied to a variety of fields. The present disclosure provides example embodiments of a polymer gel having excellent mechanical strength and an ability to maintain surface wetness for a longer time. Further, the present disclosure provides example embodiments of a method of preparing the polymer gel.

The present invention concerns layered foamed polymeric materials lacking discontinuities at the interface between the layers and a preparation process thereof comprising the following steps: —providing a foamable polymeric material; —solubilising said one or more foaming agents in the foamable polymeric material under pressure and at a temperature greater than 20° C.; and —releasing the pressure instantaneously; where the solubilisation step is carried out with a pressure profile of said one or more foaming agents that is variable over time.

A carbon fiber-based conductive sponge for low electrode-skin impedance biosignal recordings is described. When the sponge is used with water or saline solution, no gel is required, drastically lowering the setup time for EEGs compared to classical wet electrodes. The wet sponges achieve an electrode-skin impedance as low as 2.5 kٶ when wet, making them better than state of the art gel electrodes. Additionally, even as the sponge dries, it continues to remain conductive and performs as a reliable dry electrode.

Organic solid three-dimensional polymeric foams, a process for preparing the same, and use thereof, the foams includes a solid continuous phase and pores, wherein the foams have a pore size ranging from 50 nm to 200 μm and a volumetric fraction of the solid continuous phase is from 0.1 to 60%, with respect to the total volume of the foams, and a polydispersity index from 1 to 30%, the foams being ordered over a volume of at least 100 pores.

The present invention is directed to tissue sealant compositions comprising: a multi-arm reactive polyethylene glycol polymer having at least 3 electrophilic groups; albumin; a buffer; water; and entrained gas as bubbles; wherein concentration of albumin in a liquid component of the sealant is within range of 50-200 mg/ml; and wherein concentration of multi-arm PEG in said liquid component of the sealant is within range of 25-100 mg/mL.

The present invention concerns methods of administering a therapeutically effective dose of a sorbent for an inflammatory mediator to a patient where the inflammatory mediator is one or more of enzymes, cytokines, prostaglandins, eicosanoids, leukotrienes, kinins, complement, coagulation factors, endotoxins, enterotoxins, lipopolysaccharide, cell fragments, bile salts, fatty acids, phospholipids, interferon and immunomodulatory antibodies, biologics or drugs.

Covalently cross-linked copolymers are described herein. More specifically, polysaccharide-polyamine copolymeric matrices or structures and cationic copolymeric matrices are described herein. The polysaccharide-polyamine copolymers, when protonated, can form cationic copolymeric matrices having exceptionally high densities of cationic sites. In one form, the covalently cross-linked copolymers provide a three-dimensional structure, especially when hydrated.

Disclosed is a pharmaceutical composition for treating hypercholesterolemia. The pharmaceutical composition includes a polysaccharide-polyamine copolymer and a pharmaceutically acceptable salt thereof as active ingredients. The polysaccharide-polyamine copolymer is formed by copolymerization of the following two parts: a selectively oxidized polysaccharide with 2,3-dialdehyde, and a polyamine with an amino functional group; the polyamine with an amino functional group and the selectively oxidized polysaccharide with 2,3-dialdehyde can form a net structure by means of covalent crosslinking, resulting in a hydrogel with an amino functional group or a granular polysaccharide-polyamine copolymer, wherein the amino functional group in the hydrogel with an amino functional group or the granular polysaccharide-polyamine copolymer can be protonated so as to form a cationic copolymer of a three-dimensional network structure having a protonated site, and the nitrogen content of the cationic copolymer and the nitrogen content of the polysaccharide-polyamine copolymer are above 12.3 wt %, and both the cationic copolymer and the polysaccharide-polyamine copolymer are water-insoluble.

A method for producing a foam body (10) having an internal structure (100, 200, 300), comprising the steps: I) selecting an internal structure (100, 200, 300) to be formed in the foam body (10), the structure comprising a first polymer material; II) providing a foam body (10), the foam body (10) comprising a second polymer material which is different to the first polymer material; III) injecting, by means of an injection means (20), a predefined amount of a melt of the first polymer material or a predefined amount of a reaction mixture (30, 31, 32) which reacts to form the first polymer material at a predefined location inside the foam body (10), corresponding to a volume element of the internal structure (100, 200, 300); IV) repeating step III) for further predefined locations inside the foam body (10), corresponding to further volume elements of the internal structure (10), until the internal structure (10) is formed. The invention also relates to a foam body (10) which has an internal structure (100, 200, 300) and is obtainable by the method according to the invention.